# Arve Capital

> Arve Capital is a VC fund backing Health Care, Software and Artificial Intelligence. See 11 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 11
- Last investment: Jun 2026
- Lead investor: 0%
- Last updated: Aug 2026

Arve Capital is a VC fund focused on Health Care and Software. ARVE Capital

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 5 | 45% |
| Software | 3 | 27% |
| Artificial Intelligence | 3 | 27% |
| Biotechnology | 2 | 18% |
| Manufacturing | 2 | 18% |

13 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 8 | 73% |
| Pre-Seed | 2 | 18% |
| Funding Round | 1 | 9% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Germany | 6 | 55% |
| Denmark | 1 | 9% |
| Switzerland | 1 | 9% |
| United Kingdom | 1 | 9% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Kyrok | Kyrok is a Berlin-based AI startup focused on supply chain teams in pharma and chemicals, with software for planning, inventory, procurement, and production. It says its tools sit on top of existing ERP systems and aim to reduce manual work and overstock/shortages. | $3.5M | Pre-Seed | Jun 23, 2026 |  |
| Mirantus Health | Mirantus is building a distributed healthcare provider to improve access to care for underserved patients. Through healthcare services (Mirantus Care) and cloud-solutions (Mirantus OS), Mirantus empowers doctors to efficiently treat patients who were difficult to reach before. This improves healthcare access for patients, allows physicians to earnmore, while saving payors billions in downstream costs. Mirantus is on a mission to get every specialist physician in Europe to participate in distributed healthcare, to improve healthcare access for 100M+ underserved patients. | $6.3M | Seed | Nov 20, 2025 |  |
| StratifAI | Building the next generation of biomarkers for precision oncology | $14.7M |  | Sep 30, 2025 |  |
| Research Grid (R.grid) | R.grid has built machine learning-based software for medical research. | $6.4M | Seed | Nov 06, 2024 |  |
| StratifAI | Building the next generation of biomarkers for precision oncology | $1.7M | Pre-Seed | Sep 02, 2024 |  |
| Vivalyx | Vivalyx Omnisol will be a process- and cost-effective one-stop solution for all preservation applications, allowing NMP without the use of blood or human products. | $5.8M | Seed | Apr 30, 2024 |  |
| IQONIC.AI | Creating AI Solutions for Skin, Hair & Inner Balance |  | Seed | Nov 10, 2023 |  |
| deepeye | deepeye® is a precision medicine platform for retinal diseases. It enables ophthalmologists to provide individual therapy to patients suffering from prevalent eye diseases like Age-related Macular Degeneration (AMD) or other retinal diseases which affect 12% of the EU+US population, thus preventing the causes of more than 66% of blindness'. | $2.7M | Seed | Nov 07, 2023 |  |
| Biograil | Biograil, founded in 2019 and led by CEO Karsten Lindhardt, is using injection molding to manufacture a device contained in a standard size capsule able to deliver active substances into the gastrointestinal wall. The Biograil device avoids mechanical moving components and makes use of the body’s own peristaltic forces to facilitate the delivery ofthe biologic efficiently into the gastrointestinal wall. |  | Seed | Oct 04, 2022 |  |
| Avelo | Avelo mission is to save lives by bringing fast and actionable infectious disease diagnoses to primary care. | $2.3M | Seed | Sep 20, 2022 |  |

10 of 11 investments shown.

## Co-investors
- [Springboard Health Angels](https://shizune.co/investors/profile/springboard-health-angels) — VC Fund, 2 deals together
- [YZR Capital](https://shizune.co/investors/profile/yzr-venture-capital) — VC Fund, 2 deals together
- [Ada Ventures](https://shizune.co/investors/profile/ada-vemtires) — VC Fund, 1 deal together
- [Alven](https://shizune.co/investors/profile/alven-capital) — VC Fund, 1 deal together
- [Arāya Ventures](https://shizune.co/investors/profile/ar%C4%81ya-ventures) — VC Fund, 1 deal together
- [Ascension Ventures](https://shizune.co/investors/profile/ascension-ventures) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund
- [HV Capital](https://shizune.co/investors/profile/holtzbrinck-ventures) — VC Fund
- [IBB Ventures](https://shizune.co/investors/profile/ibb) — VC Fund

## Featured in investor lists
- [Medical Device Investors in Switzerland](https://shizune.co/investors/medical-device-investors-switzerland)
- [Medical Device VC Funds in Germany](https://shizune.co/investors/medical-device-vc-funds-germany)

## FAQ

### What does Arve Capital invest in?

Arve Capital invests primarily in Health Care, Software and Artificial Intelligence startups, most often at Seed and Pre-Seed stage. Most of the 11 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Arve Capital last invest?

The most recent investment recorded for Arve Capital closed in Jun 2026. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co